Yanping Zhang Selected Research

Mi-2 Nucleosome Remodeling and Deacetylase Complex

3/2022	Correction to: SALL1 functions as a tumor suppressor in breast cancer by regulating cancer cell senescence and metastasis through the NuRD complex.
1/2018	SALL1 functions as a tumor suppressor in breast cancer by regulating cancer cell senescence and metastasis through the NuRD complex.
10/2009	E3 ubiquitin ligase COP1 regulates the stability and functions of MTA1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yanping Zhang Research Topics

Disease

61	Neoplasms (Cancer) 03/2022 - 11/2003
45	Infections 10/2022 - 06/2003
16	Pre-Eclampsia (Preeclampsia) 01/2022 - 03/2002
12	Breast Neoplasms (Breast Cancer) 03/2022 - 08/2010
12	Neoplasm Metastasis (Metastasis) 03/2022 - 10/2009
12	Carcinogenesis 01/2020 - 12/2005
11	Marek Disease (Marek's Disease) 09/2022 - 11/2016
8	Hearing Loss (Hearing Impairment) 08/2022 - 07/2010
8	Inflammation (Inflammations) 02/2022 - 06/2013
7	Pain (Aches) 01/2021 - 07/2009
6	Virus Diseases (Viral Diseases) 09/2022 - 01/2019
5	Ototoxicity 08/2022 - 01/2014
5	Carcinoma (Carcinomatosis) 01/2022 - 12/2005
5	Prostatic Neoplasms (Prostate Cancer) 12/2015 - 12/2004
4	Colorectal Neoplasms (Colorectal Cancer) 06/2021 - 04/2014
4	Squamous Cell Carcinoma of Head and Neck 04/2020 - 01/2015
4	Postoperative Pain 01/2020 - 04/2012
4	Bites and Stings (Sting) 01/2019 - 04/2016
4	Proteinuria 06/2003 - 02/2002
3	Starvation 12/2022 - 09/2017
3	Hypoxia (Hypoxemia) 01/2022 - 05/2005
3	Coinfection 05/2021 - 10/2019
3	Fibrosis (Cirrhosis) 01/2021 - 02/2002
3	Myocardial Infarction 01/2020 - 12/2018
3	Alzheimer Disease (Alzheimer's Disease) 12/2019 - 04/2017
3	Mitochondrial Diseases (Mitochondrial Disease) 08/2019 - 08/2009
3	Malignant Mesothelioma 07/2006 - 12/2005
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2006 - 12/2005
3	IGA Glomerulonephritis (IGA Nephropathy) 06/2002 - 02/2002
2	Erectile Dysfunction 10/2022 - 05/2004
2	Bacterial Infections (Bacterial Infection) 09/2022 - 09/2014
2	Wounds and Injuries (Trauma) 09/2022 - 05/2021
2	Lymphoma (Lymphomas) 07/2022 - 01/2019
2	Hepatitis 03/2022 - 01/2022
2	Cicatrix (Scar) 01/2022 - 06/2020
2	Obesity 01/2021 - 01/2018
2	Colonic Neoplasms (Colon Cancer) 01/2021 - 02/2017
2	Heart Failure 01/2021 - 09/2016
2	Hyperalgesia 10/2020 - 08/2005
2	Pneumonia (Pneumonitis) 05/2020 - 03/2019
2	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 01/2014

Drug/Important Bio-Agent (IBA)

34	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2002
21	VaccinesIBA 10/2022 - 02/2013
11	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2012
10	Pharmaceutical PreparationsIBA 05/2021 - 06/2002
9	CytokinesIBA 01/2019 - 09/2005
8	Messenger RNA (mRNA)IBA 01/2021 - 02/2002
7	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2014
7	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 12/2009
6	Therapeutic UsesIBA 09/2020 - 06/2002
6	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 12/2017 - 02/2008
5	EnzymesIBA 09/2022 - 09/2014
5	Combined VaccinesIBA 03/2022 - 11/2016
5	Biological ProductsIBA 01/2022 - 02/2014
5	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 12/2005
5	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2018
5	Long Noncoding RNAIBA 04/2020 - 01/2017
5	InterferonsIBA 01/2019 - 03/2015
5	Ribosomal Proteins (Ribosomal Protein)IBA 12/2016 - 02/2007
4	Transcription Factors (Transcription Factor)IBA 02/2022 - 05/2009
4	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 12/2005
4	Caspase 3 (Caspase-3)IBA 01/2021 - 08/2009
4	Antiviral Agents (Antivirals)IBA 10/2020 - 10/2015
4	Opioid Analgesics (Opioids)IBA 10/2020 - 12/2013
4	AntibodiesIBA 02/2020 - 04/2011
4	Interleukin-6 (Interleukin 6)IBA 01/2019 - 09/2005
3	Anti-Bacterial Agents (Antibiotics)IBA 12/2022 - 02/2015
3	AminoglycosidesIBA 08/2022 - 01/2014
3	Neomycin FDA LinkGeneric 08/2022 - 01/2014
3	Mi-2 Nucleosome Remodeling and Deacetylase ComplexIBA 03/2022 - 10/2009
3	GadoliniumIBA 01/2022 - 01/2019
3	Phosphotransferases (Kinase)IBA 01/2022 - 04/2016
3	Nicotine FDA Link 01/2021 - 03/2002
3	Histones (Histone)IBA 01/2020 - 10/2009
3	CreatinineIBA 03/2019 - 02/2002
3	Interferon-betaIBA 01/2019 - 01/2019
3	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2019 - 04/2016
3	Cadherins (E-Cadherin)IBA 01/2019 - 03/2011
3	Nucleosomes (Nucleosome)IBA 01/2018 - 10/2009
3	Small Interfering RNA (siRNA)IBA 01/2018 - 01/2015
3	LipidsIBA 01/2018 - 06/2002
3	Folic Acid AntagonistsIBA 07/2006 - 12/2005
3	Pemetrexed (MTA)FDA Link 07/2006 - 12/2005
2	IronIBA 12/2022 - 11/2018
2	AntioxidantsIBA 08/2022 - 01/2003
2	FlavonoidsIBA 08/2022 - 11/2016
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2022 - 01/2018
2	Charcoal (Charbon)IBA 08/2021 - 10/2010
2	Immunologic Factors (Immunomodulators)IBA 01/2021 - 01/2019
2	Fibrinogen (Factor I)FDA Link 01/2021 - 01/2015
2	fibrin fragment D (D-dimer)IBA 01/2021 - 01/2015
2	Glutamic Acid (Glutamate)FDA Link 12/2020 - 07/2013
2	Sincalide FDA Link 04/2020 - 07/2015
2	Morphine (MS Contin)FDA LinkGeneric 01/2020 - 07/2009

Therapy/Procedure

17	Therapeutics 01/2021 - 06/2002
6	Immunotherapy 01/2021 - 11/2012
5	Drug Therapy (Chemotherapy) 01/2022 - 02/2005
3	Nephrectomy 10/2019 - 12/2013
3	Aftercare (After-Treatment) 01/2016 - 06/2002
2	Lasers (Laser) 09/2020 - 02/2020